| Date | Event |
| 20-Nov-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 9-Nov-09 | ANTIGENICS INC /DE/ Files SEC form 10-Q, Quarterly Report |
| 4-Nov-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 29-Oct-09 | Antigenics Inc. Earnings Call scheduled for 11:00 am ET today |
| 29-Oct-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 21-Oct-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 18-Sep-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 11-Sep-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities |
| 13-Aug-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 10-Aug-09 | ANTIGENICS INC /DE/ Files SEC form 10-Q, Quarterly Report |
| 5-Aug-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial Statements an |
| 3-Aug-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Unregistered Sale of Equity Se |
| 30-Jul-09 | Antigenics Inc. Earnings Call scheduled for 11:00 am ET today |
| 15-Jul-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 7-Jul-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers |
| 25-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 17-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 15-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits |
| 11-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 9-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur |
| 5-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur |
| 4-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur |
| 3-Jun-09 | Price hit new 52-week high ($3.34) |
| 2-Jun-09 | Price hit new 52-week high ($1.58) |
| 1-Jun-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 1-Jun-09 | Price hit new 52-week high ($0.97) |
| 27-May-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 11-May-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 7-May-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 4-May-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events |
| 30-Apr-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| 29-Apr-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| 22-Apr-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events |
| 17-Apr-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events |
| 30-Mar-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar |
| 16-Mar-09 | ANTIGENICS INC /DE/ Files SEC form 10-K, Annual Report |
| 12-Mar-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| 19-Feb-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 4-Feb-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Costs Associated with Exit or Disposal Activities |
| 21-Jan-09 | ANTIGENICS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers |
0.49% Nasdaq 0.00%
Company Events
